Sara Kiparizoska

ORCID: 0000-0001-9470-2932
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Drug-Induced Hepatotoxicity and Protection
  • Colorectal Cancer Screening and Detection
  • Advanced Chemical Sensor Technologies
  • Gastrointestinal disorders and treatments
  • Olfactory and Sensory Function Studies
  • Inflammatory Bowel Disease
  • Biochemical Analysis and Sensing Techniques
  • Congenital Heart Disease Studies
  • Vascular anomalies and interventions
  • Natural Compound Pharmacology Studies
  • Hematopoietic Stem Cell Transplantation
  • Soft tissue tumors and treatment
  • Esophageal and GI Pathology
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Microscopic Colitis
  • Multiple Myeloma Research and Treatments
  • Electroconvulsive Therapy Studies
  • Pulmonary Hypertension Research and Treatments
  • Colorectal Cancer Treatments and Studies
  • Peripheral Artery Disease Management
  • Bipolar Disorder and Treatment
  • Liver Diseases and Immunity
  • Pharmacogenetics and Drug Metabolism
  • Neutropenia and Cancer Infections
  • Gallbladder and Bile Duct Disorders

Georgetown University
2021-2023

MedStar Georgetown University Hospital
2021-2023

University of Mississippi
2017-2019

University of Mississippi Medical Center
2017-2019

Jackson Memorial Hospital
2019

Evidence for olfactory dysfunction in schizophrenia has been firmly established. However, the typical understanding of schizophrenia, olfaction is not recognized to contribute or interact with illness. Despite solid presence its relation rest illness remains largely unclear. Here, we aimed examine functional connectivity bulb, tract, and piriform cortices isolate network that would account altered schizophrenia. We examined these specific regions order other brain associated processing Using...

10.1093/ijnp/pyx045 article EN cc-by-nc The International Journal of Neuropsychopharmacology 2017-06-03

Abstract INTRODUCTION Patients with inflammatory bowel disease (IBD) often experience symptoms such as abdominal pain, diarrhea, and bloody movements. While these traditionally guided treatment, their predictive value for progression is limited. The latest STRIDE-II guidelines recommend a comprehensive IBD management approach, an emphasis on short-term symptom relief, intermediate-term biomarker normalization, long-term achievement of endoscopic remission. This treat-to-target strategy...

10.1093/ibd/izae020.046 article EN Inflammatory Bowel Diseases 2024-01-25

We present a rare case in which malignant catatonia led to acute liver failure (ALF). A 19-year-old male was admitted for psychosis and developed ALF with peak aspartate aminotransferase alanine of 5,728 U/L 7,735 U/L, respectively, international normalized ratio 7.1. Liver biopsy showed significant confluent necrosis involving >70% the tissue. He listed transplant but ultimately taken off because improvement treatment by N-acetylcysteine infusion. Through our research, we found that...

10.7759/cureus.15242 article EN Cureus 2021-05-25

Graft-vs-host disease (GVHD) after liver transplant is a rare complication with high mortality outcomes. Because of the rarity occurrence, there no standardized consensus for treatment. Early recognition symptoms and multidisciplinary approach input from hepatology hematology important to determine treatment plan improve We present unique case 49-year-old woman who developed GVHD during coronavirus 2019 (COVID-19) infection 3 months receiving transplant. More data are needed whether COVID-19...

10.14309/crj.0000000000000971 article EN cc-by-nc-nd ACG Case Reports Journal 2023-01-01

Introduction: Biliary complications account for 10%-25% of all after liver transplant and are more commonly seen in live donor transplants (LDLT) compared to deceased (DDLT). The objective this study was compare outcomes between DDLT LDLT who underwent endoscopic retrograde cholangiopancreatography (ERCP) treatment resolve post-transplant biliary complications. Methods: We conducted a retrospective chart review patients had ERCP following from September 2011 January 2022. Outcomes included...

10.14309/01.ajg.0000950044.71450.f0 article EN The American Journal of Gastroenterology 2023-10-01

Introduction: Leiomyosarcoma (LMS) is an aggressive soft tissue tumor that rarely found in the gastrointestinal (GI) tract. Commonly misdiagnosed as a stromal (GIST), LMS incidence now more accurately identified and rarer than previously thought due to advances immunohistochemical (IHC) staining over last 20 years. can be distinguished from GIST by its distinctive IHC positive for smooth muscle actin (SMA) desmin negative markers CD117, CD34, DOG1. We present case of patient who was have...

10.14309/01.ajg.0000865528.09813.27 article EN The American Journal of Gastroenterology 2022-10-01

Introduction: Clostridium difficile infection (CDI) is one of the most common hospital-acquired infections and has been increasing in frequency severity worldwide. Not only does CDI cause significant patient morbidity mortality, but it also causes an increase hospital length stay healthcare costs. The primary objective this study to identify if increased use personal protective equipment (PPE) proper hand hygiene decreased rates amidst Covid-19 pandemic. secondary determine patients infected...

10.14309/01.ajg.0000773076.31366.cd article EN The American Journal of Gastroenterology 2021-10-01
Coming Soon ...